Skyhawk Therapeutics

Waltham, United States

Skyhawk Therapeutics is a provvider of small molecule therapeutics designed to offer therapies that correct RNA expression.

Sep 2021

Venture - Series Unknown

Biotechnology Oncology Therapeutics

Top Investors

GreatPoint VenturesFidelityRock Springs CapitalGood Growth CapitalAgent Capital

Founder Contacts

19,000+ verified contacts

Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Skyhawk Therapeutics

Who are Skyhawk Therapeutics's investors?

Skyhawk Therapeutics's investors include GreatPoint Ventures, Fidelity, Rock Springs Capital, Good Growth Capital, Agent Capital.

Where is Skyhawk Therapeutics headquartered?

Skyhawk Therapeutics is headquartered in Waltham, United States.

What does Skyhawk Therapeutics do?

Skyhawk Therapeutics is a provvider of small molecule therapeutics designed to offer therapies that correct RNA expression.

What stage is Skyhawk Therapeutics at?

Skyhawk Therapeutics is at the Venture - Series Unknown stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated September 14, 2021.

MLA

"Skyhawk Therapeutics — Funding & Investors." VCBacked, September 14, 2021, https://www.vcbacked.co/company/skyhawk-therapeutics. Accessed July 1, 2026.

APA

VCBacked. (2021). Skyhawk Therapeutics — Funding & Investors. Retrieved July 1, 2026, from https://www.vcbacked.co/company/skyhawk-therapeutics

Wikipedia (cite web)

{{cite web |title=Skyhawk Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/skyhawk-therapeutics |website=VCBacked |access-date=July 1, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated September 14, 2021.